Moving an established in-vitro assay onto a microfluidic format is not a porting exercise — it is a redesign. We have done it from wafer to readout, and we will do it with you.
Not the biology. The hydrogel that will not load reproducibly. The geometry that traps a bubble at hour fourteen. The segmentation model that was trained on someone else's cell line. We have hit all of these, and we would rather you did not.
Chip geometry, cellular interaction assays, and tumor–immune models — designed around the readout you need.
Jump to section ↓Migrate an assay that already works onto a chip-based, automated system — without losing the endpoint you trust.
Jump to section ↓Segmentation, classification, and tracking pipelines trained on your imagery and validated against your manual scoring.
Jump to section ↓Chip geometry is not packaging — it is an experimental variable. A micropillar barrier is what turns immune cell recruitment from a qualitative impression into a number. Compartment spacing sets the effector-to-target ratio you can actually control. Channel geometry decides whether a gradient forms or collapses.
Compartments, micropillar barriers, fluidic routing, and hydrogel loading strategy — designed for injection molding from the first sketch, not retrofitted for it later.
Systems where two or more cell types must meet, migrate, or signal across a defined barrier — with the interaction spatially resolvable rather than merely observed.
3D spheroid systems measuring recruitment, infiltration, and cytolytic kill for drug discovery — the assay class behind our own OncoMiMIC platform.
We preserve the endpoint you already trust, and gain the microenvironment, the throughput, and the automation you do not yet have. The readout is validated head-to-head against your gold standard before anything is declared a success.
We run your existing assay, benchmark its variance, and record where the time and the errors actually come from.
The same endpoint, redesigned for a 3D compartmentalized format.
Cell seeding, hydrogel loading, dosing, and media exchange — the steps where human hands cost you reproducibility.
A validated vision pipeline replaces manual scoring — and scores every run identically, forever.
A 24-hour live-cell acquisition produces thousands of frames. Scored by hand, in ImageJ, by whoever is available — the throughput of the whole experiment collapses to the throughput of one person's attention. Worse, it is scored slightly differently every time.
A fixed-fee assessment. We tell you whether chip format helps your assay, or whether it does not.
A prototype chip and a first dataset. The goal is to fail fast if it is going to fail.
A validated assay on production chips, benchmarked head-to-head against your incumbent method.
Chips supplied, protocols documented, your scientists trained. You own the assay.
Our CEO built and scaled a semiconductor fabrication business to 1,000 wafers a month in an ISO 9001 facility. We know what makes a chip manufacturable, because we make them.
Our CSO is the named inventor on the core US microfluidics patent, licensed from A*STAR, with 15+ years of microfluidics R&D behind it.
Everything we would build for you, we built for our own platform first. Our services are how we prove the stack works — and how the industry migrates toward it.
Fixed fee, no commitment beyond it. We will tell you honestly whether a chip format helps your assay — including when the answer is no.
Book a scoping call →